The distribution of the global is heavily influenced by the varying prevalence of the disease and the level of healthcare infrastructure across different continents. Asia-Pacific, encompassing countries like India and China, holds a significant market share and is projected to be the fastest-growing region. This is primarily due to the overwhelming burden of canine-mediated human rabies...

"Regional Overview of Executive Summary Human Rabies Vaccines Market by Size and Share Data Bridge Market Research analyses a growth rate in the human rabies vaccines market in the forecast period 2023-2030. The expected CAGR of the human rabies vaccines market tends to be around 4.7% in the mentioned forecast period. The market was valued at USD 963.53 million in 2022 and would grow...

North America holds a notable share of the human rabies immunoglobulin market, driven by high awareness regarding rabies prevention, robust healthcare spending, and established treatment guidelines for post-exposure prophylaxis. The region benefits from strong pharmaceutical manufacturing capabilities, advanced healthcare facilities, and ongoing public health initiatives focused on infectious...